magnolol has been researched along with Atrophy, Muscle in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SZ; Ge, Z; Li, Y; Liu, D; Shang, Y | 1 |
| Chen, MC; Chen, YL; Chou, TC; Hung, CH; Lee, CF | 1 |
2 other study(ies) available for magnolol and Atrophy, Muscle
| Article | Year |
|---|---|
Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Biphenyl Compounds; Cachexia; Cell Line, Tumor; Humans; Lignans; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Myostatin; Neoplasms; Transfection | 2020 |
Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.
Topics: Animals; Biphenyl Compounds; Body Weight; Forkhead Box Protein O3; Forkhead Transcription Factors; Insulin-Like Growth Factor I; Interleukin-6; Lignans; Male; Mice; Mice, Nude; Muscular Atrophy; NF-kappa B; Proteasome Endopeptidase Complex; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 2015 |